Role of the subthalamo-nigral input in the control of amygdala-kindled seizures in the rat

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 78-83

  Deransart, Colin ^a   Lê, Bich Thuy ^a   Marescaux, Christian ^a   Depaulis, Antoine ^a  

^a INSERM   (France)

Author keywords

Amygdala kindled seizure; Basal ganglia; Epilepsy; Substantia nigra pars reticulata; Subthalamic nucleus

Indexed keywords

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; ENZYME INHIBITION; EPILEPSY; GABAERGIC TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEIZURE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

AMYGDALA; ANIMALS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; FUNCTIONAL LATERALITY; GABA AGONISTS; KINDLING, NEUROLOGIC; MALE; MICROINJECTIONS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SUBSTANTIA NIGRA; THALAMIC NUCLEI;

EID: 0032487662     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00745-8     Document Type: Article

References (25)

1. Alexander G., Crutcher M. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
2. Clark M., Post R., Weiss S., Cain C., Nakajima T. Regional expression of c-fos mRNA in rat brain during the evolution of amygdala kindled seizures. Mol. Brain Res. 11:1991;55-64.
3. Depaulis A., Vergnes M., Marescaux C. Endogenous control of epilepsy - the nigral inhibitory system. Prog. Neurobiol. 42:1994;33-52.
4. Deransart C., Marescaux C., Depaulis A. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat. Neuroscience. 71:1996;721-728.
5. Engel J. Jr., Wolfson L., Brown L. Anatomical correlates of electrical and behavioral events to amygdaloid kindling. Ann. Neurol. 3:1978;538-544.
6. Féger J., Robledo P. The effects of activation or inhibition of the subthalamic nucleus on the metabolic and electrophysiological activities within the pallidal complex and the substantia nigra in the rat. Eur. J. Neurosci. 3:1992;947-952.
7. Gale K. Mechanisms of seizure control mediated by gamma aminobutyric acid: role of the substantia nigra. Fed. Proc. 44:1985;2414-2424.
8. L. Heimer, D. Zahm, G. Alheid, Basal ganglia, in: G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, CA, 1995, pp. 579-628.
9. Helfer V., Deransart C., Marescaux C., Depaulis A. Amygdala kindling in the rat: anxiogenic-like consequences. Neuroscience. 73:1996;971-978.
10. Kokaia M., Aebischer P., Elmer E., Bengzon J., Kalén P., Kokaia Z., Lindvall O. Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not noradrenaline-releasing polymer matrices. Exp. Brain Res. 100:1994;385-394.
11. Le Gal La Salle G., Kaijima M., Feldblum S. Abortive amygdaloid kindled seizures following microinjection of γ-vinyl-GABA in the vicinity of substantia nigra in rats. Neurosci. Lett. 36:1983;69-74.
12. Löscher W., Czuczwar S., Jäkel R., Schwartz M. Effect of microinjections of gamma-vinyl-GABA or isoniazid into the substantia nigra on the development of amygdala kindling in rats. Expl. Neurol. 95:1987;622-638.
13. Maggio R., Gale K. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra. Exp. Neurol. 105:1989;184-188.
14. McNamara J., Galloway M., Rigsbee L., Shin C. Evidence implicating substantia nigra in regulation of kindled seizure threshold. J. Neurosci. 4:1984;2410-2417.
15. McNamara J.O. Kindling, an animal model of complex partial epilepsy. Ann. Neurol. 16:1984;S72-S76.
16. Meldrum B., Millan M., Patel S., De Sarro G. Anti-epileptic effects of focal micro-injection of excitatory amino acid antagonist. J. Neural Transm. 72:1988;191-200.
17. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50:1996;381-425.
18. Mohapel P., Dufresne C., Kelly M.E., Mcintyre D.C. Differential sensitivity of various temporal lobe structures in the rat to kindling and status epilepticus induction. Epilepsy Res. 23:1996;179-187.
19. Osonoe M., Mori N., Hoshino S., Yamada Y., Osonoe K., Kittaka H., Iwata Y. The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats. Brain Res. 728:1996;242-246.
20. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986.
21. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
22. P. Redgrave, T.J. Prescott, K. Gurney, The basal ganglia: a neural architecture for conflict resolution, Ann. Meeting Soc. Neurosci. Abstr., Vol. 23, New Orleans, 1997, p. 192.
23. Schmutz M., Jeker A.K.K., Portet C., Pozza M., Fagg G.E., Heckendorn R., Allgeier H. CGP 40116/CGP 43487: competitive N-methyl-D-aspartate antagonists with potent oral anticonvulsant activity. Epilepsia. 32:1991;59-60.
24. Veliskova J., Velsek L., Moshe S.L. Subthalamic nucleus: a new anticonvulsant site in the brain. NeuroReport. 7:1996;1786-1788.
25. Wurpel J.N.D., Sperber E.F., Moshé S.L. Age-dependent differences in the anticonvulsant effects of 2-amino-7-phosphono-heptanoic acid or ketamine infusions into the substantia nigra of rats. Epilepsia. 33:1992;439-443.